| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | General Counsel
2 companies
Jane Wright-Mitchell is Chief Legal Officer at VERA and has filed Form 4s across 2 companies. Jane Wright-Mitchell's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.5M at current prices.
Historically, Jane Wright-Mitchell's trades have earned a middling insider score of 65/100 across 3 rated trades. Over a 12-month horizon, all 3 of those trades were profitable, with an average 12-month return of +4.2%.
The biggest single holding is VERA (~$1.3M) as Chief Legal Officer.
Jane Wright-Mitchell has 9 Form 4 filings on record from February 2016 to March 2026, across 3 companies: Chief Legal Officer at Vera Therapeutics (VERA), 2026; General Counsel at Vaxcyte (PCVX), 2021; Chief Legal Officer at Talphera (TLPH), 2016–2017.
The 16 reported transactions were 6 open-market sales, 5 option exercises, 4 option or other derivative awards and 1 stock award.
Counted by filing, the open-market trades come to no purchases and 5 sales worth about $526K.
The largest open-market sale was 10,000 shares of PCVX at an average $26.00 on August 12, 2021, about $260K. Twelve months later PCVX was down 1%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 | PCVX Vaxcyte, Inc. | General Counsel | Sale+OE | 2,500 | $26.00 | $65,000.00 | -44.4% | -0.8% | -3.3% | |
| Aug 12, 2021 | PCVX Vaxcyte, Inc. | General Counsel | Sale+OE | 10,000 | $26.00 | $260,000.00 | -76.2% | -7.5% | -1.1% | |
| Mar 15, 2021 | PCVX Vaxcyte, Inc. | General Counsel | Sale+OE | 2,500 | $27.30 | $68,238.76 | -61.5% | -15.1% | -8.1% | |
| Feb 16, 2021 | PCVX Vaxcyte, Inc. | General Counsel | Sale+OE | 2,500 | $26.95 | $67,375.00 | -61.5% | - | - | |
| Jan 15, 2021 | PCVX Vaxcyte, Inc. | General Counsel | Sale+OE | 2,500 | $26.00 | $65,000.00 | -61.5% | - | - |